Angiotensin receptor blockers associated with lower risk of Alzheimer's disease

Researchers from Boston University School of Medicine (BUSM) have found that angiotensin receptor blockers (ARBs) -- a particular class of anti-hypertensive medicines -- are associated with a striking decrease in the occurrence and progression of dementia. These findings appear in the January issue of the British Medical Journal.

Read the whole article on Physorg

More from Physorg